CN103110847B - TCM (traditional Chinese medicine) preparation for treating endometriosis - Google Patents

TCM (traditional Chinese medicine) preparation for treating endometriosis Download PDF

Info

Publication number
CN103110847B
CN103110847B CN201310067242.8A CN201310067242A CN103110847B CN 103110847 B CN103110847 B CN 103110847B CN 201310067242 A CN201310067242 A CN 201310067242A CN 103110847 B CN103110847 B CN 103110847B
Authority
CN
China
Prior art keywords
radix
herba
chinese medicine
preparation
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310067242.8A
Other languages
Chinese (zh)
Other versions
CN103110847A (en
Inventor
黄静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUANG Jing
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310067242.8A priority Critical patent/CN103110847B/en
Publication of CN103110847A publication Critical patent/CN103110847A/en
Application granted granted Critical
Publication of CN103110847B publication Critical patent/CN103110847B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a TCM (traditional Chinese medicine) preparation for treating endometriosis. The endometriosis belongs to the category of dysmenorrheal and menoxenia and the like, and mainly has symptoms such as abdominal pains and dysmenorrheal and the like caused by that the blood stasis lasts for a long time, and stagnation leads to pain after the qi-blood circulation is sluggish and the circulation of menstrual blood in the uterus is blocked due to artificial abortion, abortion, induced abortion and postoperative blood stasis. Therefore, the preparation disclosed by the invention is implemented through selecting traditional Chinese medicines such as jasminum laurifolium, Chinese leontopodium roots, sticktight, Stephania tetrandra S. Moore var. glabra Maxim, wild clove roots, gynura pseudochina, loosestrife, paleaceous Knotweed rhizome, latifolious rush rhizome, bighead atractylodes rhizome, phaenosperma globosa, fiveleaf akebia fruits, clinopodium megalanthum, viola orientalis, and arachnoid cyanotis roots, and preparing the traditional Chinese medicines into a decoction. Through clinical trials, the total effective rate is 96.7%, and the dysmenorrheal improvement rate is 96.0%, which are both superior to those in a control group; and especially the TCM preparation has no side effect in a treatment group.

Description

A kind of Chinese medicine preparation for the treatment of endometriosis
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of Chinese medicine preparation for the treatment of metrecotpia disease.
Background technology
Endometriosis refers to that the endometrial tissue with growth function appears at a kind of disease caused by other positions of health beyond cavity of uterus mucosa, belongs to the difficult and complicated illness of gynecological.Be current common gynecological disease, frequently-occurring disease, according to relevant statistics, in endometriosis patients, 80% has obvious dysmenorrhea, and 30%-50% merges infertile, this disease be mainly in 25-45 year Women of Childbearing Age, have a strong impact on patient's physically and mentally healthy and quality of life.Utilize Western medicine and abdominal to treat equal Shortcomings part clinically, recurrence and probability of again performing the operation all higher, side effect is large, and curative effect is unsatisfactory.Chinese traditional treatment has good effect, the advantage that side effect is little.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine preparation for the treatment of endometriosis.Endometriosis belongs to the categories such as traditional Chinese medical science dysmenorrhea, menoxenia, is mostly due to retention of blood stasis after fetal abortion, abortion, artificial abortion, operation, and long-pending stasis of blood punching is appointed, or cold accumulating in meridian, make QI-blood circulation not smooth, the circulation of uterus menses is hindered, and stasis of blood day of year is of a specified duration, stagnation of QI and blood may bring about pain, causes lower abdomen pain, the symptoms such as dysmenorrhea.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine preparation of this treatment endometriosis is made up of the Chinese medicine of following weight portion: Herba Jasmini laurifolii 10-20 part, Radix leontopodii sinensis 5-10 part, Herba Bidentis Bipinnatae 7-10 part, Radix Cissi Kerrii 5-7 part, Radix Luculiae intermediae 9-12 part, Gynura bodinieri Levl. 3-7 part, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 7-10 part, Rhizoma Polygoni Paleachi 10-15 part, Juncus amplifolius A. Camus 6-9 part, Rhizoma Atractylodis Macrocephalae 6-9 part, Herba Phaenospermatis globosae 10-15 part, Fructus Akebiae 3-5 part, Herba Stellariae paniculigerae 7-10 part, Radix violae delavayi 6-8 part, Radix Cyanotis arachnoideae 7-9 part.
Preferably, Herba Jasmini laurifolii 15 parts, Radix leontopodii sinensis 8 parts, Herba Bidentis Bipinnatae 9 parts, Radix Cissi Kerrii 6 parts, Radix Luculiae intermediae 11 parts, Gynura bodinieri Levl. 6 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 8 parts, Rhizoma Polygoni Paleachi 12 parts, Juncus amplifolius A. Camus 7 parts, the Rhizoma Atractylodis Macrocephalae 8 parts, Herba Phaenospermatis globosae 13 parts, Fructus Akebiae 4 parts, Herba Stellariae paniculigerae 9 parts, Radix violae delavayi 7 parts, Radix Cyanotis arachnoideae 8 parts.
Preparation method uses boiling machine, and become every pair to be 200ml above-mentioned Chinese medicine decocting, every 100ml mono-bag is for subsequent use.
Fang Zhong: Herba Jasmini laurifolii, Radix leontopodii sinensis, Herba Bidentis Bipinnatae, Radix Cissi Kerrii heat-clearing and toxic substances removing, antiinflammatory diuresis, detumescence dissipating blood stasis; Radix Luculiae intermediae, Gynura bodinieri Levl., Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) promoting blood flow to regulate menstruation, anti-inflammatory analgetic; Rhizoma Polygoni Paleachi, Juncus amplifolius A. Camus fall apart blood hemostasis, regulating QI to relieve pain; The Rhizoma Atractylodis Macrocephalae, Herba Phaenospermatis globosae air making-up and spleen enlivening, dampness diuretic; Fructus Akebiae, Herba Stellariae paniculigerae depressed liver-energy dispersing and QI regulating, promoting blood circulation and stopping pain; Radix violae delavayi, Radix Cyanotis arachnoideae promoting the flow of QI in the collateral by warming the meridian, removing damp and stopping pain.
Clinical data
1, physical data my gynecological of institute in month November in August, 2007 to 2010 treat altogether endometriosis patients 120 example, patient is divided into treatment group and matched group at random, treatment group patient 60 example, the age at 25 ~ 45 years old, 36.8 years old mean age, the course of disease 1 ~ 5 year; Average 3.5 years, have dysmenorrhea situation person 50 example, the routine patient of matched group 60, the age at 22 ~ 48 years old, 35.6 years old mean age, the course of disease 1 ~ 6 year; Average 4 years, there is dysmenorrhea situation person 45 example.Two groups of patient ages and the data such as the state of an illness, the course of disease through statistical procedures, difference there are no significant meaning.P > 0.05, has comparability.
2, Therapeutic Method treatment group takes Chinese medicine preparation of the present invention, prescription is: Herba Jasmini laurifolii 15g, Radix leontopodii sinensis 8g, Herba Bidentis Bipinnatae 9g, Radix Cissi Kerrii 6g, Radix Luculiae intermediae 11g, Gynura bodinieri Levl. 6g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 8g, Rhizoma Polygoni Paleachi 12g, Juncus amplifolius A. Camus 7g, Rhizoma Atractylodis Macrocephalae 8g, Herba Phaenospermatis globosae 13g, Fructus Akebiae 4g, Herba Stellariae paniculigerae 9g, Radix violae delavayi 7g, Radix Cyanotis arachnoideae 8g, use boiling machine, decocting into every secondary Chinese medicine is 200ml, every 100ml mono-bag, every day 2 times, each 100ml divides early, evening 2 times is oral, non-menstrual period are oral, and serveing on 3 months is 1 course for the treatment of.Matched group starts that danazol capsule of oral pill from menstruation the 1st day, and each serving with 0.2g, every day 2 times, serveing on 3 months is 1 course for the treatment of, terminates rear judgement curative effect the course for the treatment of.
3, criterion of therapeutical effect (1) reference " combination of Chinese and Western medicine diagnosis and treatment standard of Endometriosis) " formulate.Recovery from illness: symptom (comprising blood stasis syndrome) all disappears, the local such as pelvic lump sign disappears substantially, gestation or fertility in Sterility patient 3 years; Effective: symptom disappears substantially, pelvic lump reduces (compared with menstrual cycle inspection of the same period), though local sign exists, Sterility patient is become pregnant; Effective: symptom alleviates, pelvic lump is without increase or reduce slightly again, and drug withdrawal symptom in March does not increase the weight of, invalid: cardinal symptom is unchanged or worsen, and local patholoic change is in increasing the weight of trend.
(2) dysmenorrhea improves the diagnostic criteria of criterion of therapeutical effect with reference to version " new Chinese medicine guideline of clinical investigations " uterine displacement disease in 1997: recovery from illness: after treatment, primary symptom integration reduces > 4/5 before comparatively treating; Effective: after treatment, primary symptom integration reduces 1/2=4/5 before comparatively treating; Effective: after treatment, integration comparatively treats front minimizing >=1/3 but < 1/2; Invalid: after treatment, primary symptom integration reduces < 1/3 before comparatively treating.
4, therapeutic outcome (1) two group of patient treatment after 3 months comparitive study in table 1.
Table 1 liang group patient clinical comparitive study table
Treatment group total effective rate is 96.7%; Matched group total effective rate is 80.0%; Two groups are compared cure rate, and total effective rate treatment group is obviously better than matched group, and difference has significant.
(2) two groups of patient's dysmenorrheas are improved situation and are compared in table 2.
A table 2 liang group patient dysmenorrhea improves situation comparison sheet
Two groups of patient's dysmenorrheas are improved situation and are compared, and it is 96.0% that treatment group patient dysmenorrhea improves total effective rate, and matched group is 66.7%, two groups and compares, and diversity is very significant (P < 0.01).Dysmenorrhea is improved treatment group and is better than matched group.
5, untoward reaction treatment group does not find any side effect, drug safety; Matched group some patients has obvious side effect, 4 examples of wherein body weight increase, occurs 9 examples of edema, 7 examples of flush, and sound becomes 9 hoarse examples.
Detailed description of the invention
Embodiment one: take Herba Jasmini laurifolii 15g, Radix leontopodii sinensis 8g, Herba Bidentis Bipinnatae 9g, Radix Cissi Kerrii 6g, Radix Luculiae intermediae 11g, Gynura bodinieri Levl. 6g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 8g, Rhizoma Polygoni Paleachi 12g, Juncus amplifolius A. Camus 7g, Rhizoma Atractylodis Macrocephalae 8g, Herba Phaenospermatis globosae 13g, Fructus Akebiae 4g, Herba Stellariae paniculigerae 9g, Radix violae delavayi 7g, Radix Cyanotis arachnoideae 8g.Use boiling machine, become every pair to be 200ml above-mentioned Chinese medicine decocting, every 100ml mono-bag is for subsequent use.
Embodiment two: take Herba Jasmini laurifolii 10g, Radix leontopodii sinensis 5g, Herba Bidentis Bipinnatae 10g, Radix Cissi Kerrii 5g, Radix Luculiae intermediae 12g, Gynura bodinieri Levl. 3g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 10g, Rhizoma Polygoni Paleachi 10g, Juncus amplifolius A. Camus 6g, Rhizoma Atractylodis Macrocephalae 9g, Herba Phaenospermatis globosae 10g, Fructus Akebiae 3g, Herba Stellariae paniculigerae 10g, Radix violae delavayi 6g, Radix Cyanotis arachnoideae 9.Preparation method embodiment one.
Embodiment three: take Herba Jasmini laurifolii 20g, Radix leontopodii sinensis 10g, Herba Bidentis Bipinnatae 7g, Radix Cissi Kerrii 7g, Radix Luculiae intermediae 9g, Gynura bodinieri Levl. 7g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 7g, Rhizoma Polygoni Paleachi 15g, Juncus amplifolius A. Camus 9g, Rhizoma Atractylodis Macrocephalae 6g, Herba Phaenospermatis globosae 15g, Fructus Akebiae 5g, Herba Stellariae paniculigerae 7g, Radix violae delavayi 8g, Radix Cyanotis arachnoideae 7g.Preparation method embodiment one.

Claims (1)

1. treat a Chinese medicine preparation for endometriosis, it is characterized in that this Chinese medicine preparation is made up of the Chinese medicine of following weight: Herba Jasmini laurifolii 15g, Radix leontopodii sinensis 8g, Herba Bidentis Bipinnatae 9g, Radix Cissi Kerrii 6g, Radix Luculiae intermediae 11g, Gynura bodinieri Levl. 6g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 8g, Rhizoma Polygoni Paleachi 12g, Juncus amplifolius A. Camus 7g, Rhizoma Atractylodis Macrocephalae 8g, Herba Phaenospermatis globosae 13g, Fructus Akebiae 4g, Herba Stellariae paniculigerae 9g, Radix violae delavayi 7g, Radix Cyanotis arachnoideae 8g.
CN201310067242.8A 2013-02-20 2013-02-20 TCM (traditional Chinese medicine) preparation for treating endometriosis Expired - Fee Related CN103110847B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310067242.8A CN103110847B (en) 2013-02-20 2013-02-20 TCM (traditional Chinese medicine) preparation for treating endometriosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310067242.8A CN103110847B (en) 2013-02-20 2013-02-20 TCM (traditional Chinese medicine) preparation for treating endometriosis

Publications (2)

Publication Number Publication Date
CN103110847A CN103110847A (en) 2013-05-22
CN103110847B true CN103110847B (en) 2015-05-13

Family

ID=48409254

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310067242.8A Expired - Fee Related CN103110847B (en) 2013-02-20 2013-02-20 TCM (traditional Chinese medicine) preparation for treating endometriosis

Country Status (1)

Country Link
CN (1) CN103110847B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103316165B (en) * 2013-07-05 2014-09-10 魏法虹 Chinese herbal enema for treating pelvic inflammatory masses
CN103705823B (en) * 2013-12-22 2016-06-29 李光彩 A kind of Chinese medicine preparation treating cold blood stasis card primary dysmenorrhea

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102727715A (en) * 2012-07-04 2012-10-17 杜晓娅 Traditional Chinese medicine preparation of treating chronic pyelonephritis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102727715A (en) * 2012-07-04 2012-10-17 杜晓娅 Traditional Chinese medicine preparation of treating chronic pyelonephritis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
用活血化瘀法治疗肾盂肾炎的体会;李汉俊;《陕西中医》;19801231;第01卷(第03期);15-16,第16页右栏第2段 *

Also Published As

Publication number Publication date
CN103110847A (en) 2013-05-22

Similar Documents

Publication Publication Date Title
CN103656041B (en) A kind of Chinese medicine for the treatment of cervical cancer
CN103585378B (en) A Chinese medicinal composition for treating female infertility, and its preparation method
CN101954037B (en) Chinese medicinal preparation for treating prostatitis
CN102671135B (en) Chinese medicinal composition for treating ovarian cyst, and preparation method thereof
CN102133376A (en) Formula of Chinese medicinal herb for conditioning myoma of uterus
CN103110847B (en) TCM (traditional Chinese medicine) preparation for treating endometriosis
CN102973677B (en) Traditional Chinese medicine for treating ovarian cyst
CN107375883A (en) A kind of semifluid extract of deer foetus for treating infertility, endometriosis and dysmenorrhoea
CN103316238B (en) Traditional Chinese medicine for treating infertility due to cold uterus
CN104547700B (en) A kind of Chinese medicine composition for the treatment of preceeded menorrhea
CN104288581A (en) Traditional Chinese medicine for treating threatened abortion
CN104547396A (en) Traditional Chinese medicinal composition for treating delayed menstrual cycle
CN104173896A (en) Traditional Chinese medicine preparation for treating amenorrhoea
CN102343009A (en) Traditional Chinese medicine for treating dysmenorrhea
CN101062137B (en) Chinese medicine for curing female emmeniopathy
CN105311396A (en) Traditional Chinese medicine preparation for treating hypomenorrhea caused by thin endometrium
CN105597020A (en) Pharmaceutical composition for treating polycystic ovarian syndrome combined with mammary gland hyperplasia
CN105663577A (en) Traditional Chinese medicine composition for postpartum care and preparation method thereof
CN104587155B (en) A kind of medicament for the treatment of uterine prolapse
CN105688175A (en) Traditional Chinese medicine preparation for treating polycystic ovarian syndrome
CN105395768A (en) Pharmaceutical composition for treating qi-blood deficiency type hypomenorrhea
CN105535199A (en) Pharmaceutical preparation for treating polycystic ovarian syndromes accompanied with mammary gland hyperplasia
CN104721549A (en) Traditional Chinese medicine for treating recurrent abortion
CN104740040A (en) Traditional Chinese medicine decoction for treating irregular menstruation
CN103990082A (en) Traditional Chinese medicine for treating gynecological inflammation and manufacturing method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: HUANG JING

Free format text: FORMER OWNER: AI BAIYUAN

Effective date: 20150410

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Huang Jing

Inventor before: Ai Baiyuan

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 250011 JINAN, SHANDONG PROVINCE TO: 276000 LINYI, SHANDONG PROVINCE

Free format text: CORRECT: INVENTOR; FROM: AI BAIYUAN TO: HUANG JING

TA01 Transfer of patent application right

Effective date of registration: 20150410

Address after: The Affiliated Hospital of Jintan road 276000 in Shandong province Linyi City Lanshan District No. 80 Shandong Medical College

Applicant after: Huang Jing

Address before: 250011 Shandong Province, Ji'nan City Cultural Road No. 42 Shandong Province Hospital of traditional Chinese Medicine

Applicant before: Ai Baiyuan

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150513

Termination date: 20160220

CF01 Termination of patent right due to non-payment of annual fee